Axon Enterprise, Inc. filings document operating results and corporate actions for a public safety technology company with Software & Services and Connected Devices activities. Form 8-K reports include shareholder letters on financial results and outlooks, product demand across TASER devices, Axon Body cameras, Axon Evidence, AI products, counter-drone offerings and real-time operations, as well as material-event disclosures tied to capital structure.
Proxy materials cover board composition, shareholder meeting matters, executive compensation and equity awards. Other 8-K and 8-K/A filings record director election updates and the redemption and settlement of 0.50% convertible senior notes due 2027, including the disclosure that no convertible notes remained outstanding after the redemptions and conversions.
AXON ENTERPRISE, INC. (AXON) reported that Chief Revenue Officer Cameron Brooks had 734.82 shares of common stock withheld on August 31, 2026 to pay tax liability arising from the vesting of restricted stock units. The shares were valued at $566.56 per share, and Brooks now directly holds 67,246.113 shares.
AXON ENTERPRISE, INC. (AXON) reported that officer Elizabeth Reid Coughlin, Chief Human Officer, had 479.268 shares of common stock withheld on August 31, 2026 to satisfy tax liability from the vesting of restricted stock units. The shares were valued at $566.56 per share, and she now directly holds 40,362.565 shares of AXON common stock. No Rule 10b5-1 trading plan is reported.
AXON ENTERPRISE, INC. (AXON) reported that Chief Legal Officer Isaiah Fields had 763.159 shares of common stock withheld on August 31, 2026 to satisfy tax liability from the vesting of restricted stock units. These shares were disposed of at a reported value of $566.56 per share, leaving him with 57,280.855 shares held directly.
AXON ENTERPRISE, INC. (AXON) reported that its president, Joshua Isner, sold a total of 16,775 shares of common stock on August 31, 2026. The 28 open-market sale transactions were executed at weighted average prices generally between about $561 and $595 per share, and were effected pursuant to a Rule 10b5-1 trading plan adopted on June 1, 2026. The shares sold were issued upon settlement of vested restricted stock units.
Axon Enterprise, Inc. (AXON) is named as the issuer in a notice of proposed resale of common stock under Rule 144 filed for the account of officer Joshua Isner. The filing covers a proposed sale of 16,775 shares of common stock through J.P. Morgan Securities LLC, with an aggregate market value of $10,077,245.75, when Axon had 81,237,415 shares outstanding as of 08/31/2026. The shares were acquired via RSU vesting on 08/13/2026 as compensation from the issuer.
The filing also reports that, during the prior three months, the Stool and Stars Revocable Trust, for which Joshua Isner serves as trustee, sold 34,000 shares of Axon common stock on 06/05/2026 for $16,589,351.40. The new shares covered by this notice are to be sold by that same trust.
AXON ENTERPRISE, INC. (AXON) reported that its CPO & CTO, Jeffrey C. Kunins, executed multiple open-market sales of 9,605 shares of common stock on August 21, 2026. The sales, at prices around $605.77–$635.02 per share, were effected under a Rule 10b5-1 trading plan and involved shares issued upon settlement of vested restricted stock units. Following these transactions, Kunins is reported to indirectly own 86,268 shares through an LLC of which he is the sole member.
Axon Enterprise, Inc. (AXON) received a Rule 144 notice stating that officer Jeffrey C. Kunins plans a potential sale of up to 9,605 shares of common stock through Morgan Stanley Smith Barney LLC. The filing lists an aggregate market value of $5,899,967.30 for these securities and notes 81,237,415 shares of common stock outstanding as of 08/21/2026 on NASDAQ. The shares to be sold were acquired from the issuer as Restricted Stock Units on 08/13/2026.
AXON ENTERPRISE, INC. executive Jeffrey C. Kunins reported equity compensation and related tax withholding activity. On August 16, 2026, he acquired 20,618 shares of common stock tied to a certified fourth tranche of performance-based restricted stock units under the 2024 eXponential Stock Plan and a supplemental grant of 3,753 shares, both at $0.00 per share. On August 13, 2026, 6,232.647 shares were disposed at $615.59 per share, representing shares withheld to settle tax liability from RSU vesting. He also reports 86,268 shares held indirectly through an LLC of which he is the sole member.
AXON ENTERPRISE, INC. president Joshua Isner reported equity compensation activity. On August 16, 2026 he acquired 67,910 performance-based restricted stock units (XSUs) tied to a tranche under the 2024 eXponential Stock Plan whose performance conditions were certified, which will vest on December 1, 2026 and then be subject to a minimum holding period. He also received a supplemental equity grant of 14,218 shares. On August 13, 2026, 15,704.08 shares were withheld at $615.59 per share to settle tax liabilities from vesting restricted stock units.
AXON ENTERPRISE, INC. reported that COO & CFO Brittany Bagley had two equity-related transactions in company common stock. On August 16, 2026, she acquired 30,560 performance-based restricted stock units (XSUs) for which the fourth tranche’s performance conditions were certified as met; this tranche is scheduled to vest on December 1, 2026, subject to continued employment, and the shares will be subject to a minimum holding period until the earlier of December 31, 2030 or the vesting of a subsequent tranche, excluding shares used for taxes. On August 13, 2026, 8,708.157 shares were disposed at $615.59 per share, representing shares withheld to settle her tax liability from vesting restricted stock units.